Emtricitabine And Tenofovir Disoproxil Fumarate
Product Images NDC 67296-1433

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 67296-1433). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3 Count Epm (67296 1433 3)

FDA Label Image

Chemical Structure (Image 1)

FDA Label Image

Tenofovir Fumurate Chemical Structure (Image 2)

FDA Label Image

1 (Image 3)

This is a prescription medication used to treat HIV infection. Each bottle contains 30 tablets of Emtricitabine and Tenofovir Disoproxil Fumarate Tablets. The medication guide should be dispensed with each prescription. The product code is NDC 0093-7607-56 and the lot number is 70063598 Ry A 12/2019.*

FDA Label Image

2 (Image 4)

This is a description of a prescription medication called "Disoproxil Fumarate Emtricitabine and Tablets." Each film-coated tablet contains 200mg of Emtricitabine and 300mg of Tenofovir disoproxil fumarate (equivalent to 245 mg tenafour disoproxi). The usual dosage information can be found in the package insert, and it should be stored at 20°C to 25°C (68°F to 77°F). The medication should be kept in the original container and away from children. The manufacturer is Pliva Hrvatska d.o.o in Croatia and is made for Teva Pharmaceuticals USA, Inc. The medication guide should be dispensed to each patient.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.